University of Texas Health Science Center at Houston: Kolonin, Gutierrez Publish Diabetes Research In Cell Reports Medicine
December 03, 2022
December 03, 2022
HOUSTON, Texas, Dec. 3 (TNSjou) -- The University of Texas Health Science Center at Houston issued the following news:
A translational research study from collaborating UTHealth Houston laboratories of Mikhail Kolonin, PhD, and Absalon Gutierrez, MD, on the new mechanism mediating the anti-diabetic effects of incretins has been published in Cell Reports Medicine.
Kolonin is a professor and the Harry E. Bovay, Jr. Distinguished University Chair in Metabolic Disease Resea . . .
A translational research study from collaborating UTHealth Houston laboratories of Mikhail Kolonin, PhD, and Absalon Gutierrez, MD, on the new mechanism mediating the anti-diabetic effects of incretins has been published in Cell Reports Medicine.
Kolonin is a professor and the Harry E. Bovay, Jr. Distinguished University Chair in Metabolic Disease Resea . . .